Manufacturing AbbVie opts for North Carolina to house $1.4bn manufacturing site Pharmaceutical TechnologyThis Durham-based facility will be AbbVie's first manufacturing site in the state, and will become a centre of excellence for SVP production.ManufacturingRead full story pharminent April 23, 2026 (Last updated: April 23, 2026) Pharmaceutical Technology This Durham-based facility will be AbbVie’s first manufacturing site in the state, and will become a centre of excellence for SVP production. ManufacturingRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: MSD teams up with Google Cloud on agentic AI transformationNext: Sanofi receives FDA approval for Tzield in paediatric diabetes Related Stories Manufacturing FDA Warning Letter Hits Sanofi’s Genzyme Ireland Site pharminent July 8, 2026 Manufacturing Tanabe pens deal to sell plants to Towa in post-buyout pivot pharminent July 8, 2026 Manufacturing FDA Selects Seven for PreCheck Pilot to Advance Drug Manufacturing pharminent July 1, 2026
